197 medical companies changed their names: China Resources and Kyushu Express Strong Layout (with list)

Recently, Jianshangjun inquired about the procurement platform of local medicines and found that in the first four months of 2017, 11 provinces and cities such as Jiangsu, Hebei, Zhejiang and Shaanxi issued the “Notice of Change of Enterprise Name”, with a total of 197 pharmaceutical production and management. The company changed its name, including 278 production enterprises and 28 business enterprises. The information that has been repeatedly released was deleted, and a total of 197 enterprises were officially renamed.

Among the 197 renaming information, some companies have not changed much, but the company has become a joint-stock company, and some of them have changed their names. Among them, there are industrial layouts of large-scale drug dealers such as Sinopharm, Shanghai Pharmaceutical, China Resources, and Jiuzhoutong, as well as pharmaceutical companies such as Eisai, Shijiazhuang and Renfu Pharmaceutical.

Sinopharm Group: highlighting the integration of Chinese medicine platform

In the list of 197 company name changes, renamed and Sinopharm of seven companies including Zhijun Pharmaceutical, Suizhou Pharmaceutical, Guizhou Tongjitang, Guangdong Global, Fengda Pharmaceutical, Jingfang Pharmaceutical, and Chengdu Xinlibang Biological Related. However, from the name change, the name change of the Chinese medicine system is more of its own system.

According to public information, the acquisition of these companies by Sinopharm is not a recent matter. In 2013, Sinopharm Group acquired Yingtian Pharmaceutical and began to build its drug platform. Traditional Chinese medicine companies such as Guangdong Global, Fengshang Pharmaceutical, and Jingfang Pharmaceutical, which are owned by Yingtian Pharmaceutical, are included in the territory of Sinopharm Group. Nowadays, on the bidding and procurement platforms of various provinces and cities, these enterprises have officially appeared at the beginning of Chinese medicine, which may indicate that the integration of Chinese medicines by Chinese medicine group has been initially completed.

Chengdu Xinlibang Biotechnology Co., Ltd. invested and established by Wuliangye Yibin Pharmaceutical Co., Ltd., Yibin Pharmaceutical Co., Ltd. jointly invested by Sinopharm Group and Wuliangye Group to establish a subsidiary. The main products are Shengmai Injection, Xiangdan Injection, Danshen Injection, and Houttuynia Injection, San Han Jie Hot Oral Liquid, Shengmaiyin, Niuhuang Jiedu Tablet Xinqi Granules, Chuanbeiyu Syrup, etc., are also part of the layout of the traditional Chinese medicine platform.

As for Huaibei Sinopharm Far East Medicine Co., Ltd., public information shows that the company is a pharmaceutical wholesale company, Sinopharm Group Huangshan Dahe Health Industry Co., Ltd.

From the perspective of Sinopharm, in the case of a relatively complete circulation of its pharmaceuticals, we see its strong layout in the Chinese medicine industry.

Kyushutong: Rio Tinto Blank Market

Unlike Sinopharm, Kyushutong’s mergers and acquisitions are mainly concentrated in the circulation field. Weinan Zhengyuan Pharmaceutical Co., Ltd., Qinghai Dayang Pharmaceutical Co., Ltd., Anhui Shenghe Pharmaceutical Sales Co., Ltd., these three companies were changed to: Weinan Kyushu Tongzhengyuan Pharmaceutical Co., Ltd., Xining Jiuzhoutong Pharmaceutical Co., Ltd., and Xiangyang Jiuzhoutong Pharmaceutical Co., Ltd. . In the Jiuzhoutong base area of ​​Hubei Province, Huangshi Jiuzhou Tong Pharmaceutical Co., Ltd. became a personal company and was renamed Hubei Litai Pharmaceutical Co., Ltd.

Analysts said that Kyushutong is also making strategic adjustments to its marketing network, opening up blank markets and expanding its network coverage.

In the 2016 semi-annual report, Jiuzhoutong said that the company has not yet established a subsidiary or subsidiary in the provinces of Hunan, Hebei, Qinghai, Ningxia, Hainan, Yunnan, Guizhou, Shaanxi and Tibet. In the competition for drug distribution rights won the bid.

Although Jiuzhoutong of Shaanxi has been established, the semi-annual report shows that its business scope is medical consultation, not pharmaceutical sales, and there is no subsidiary in Qinghai. Therefore, mergers or acquisitions of Weinan Zhengyuan Pharmaceutical Co., Ltd. and Qinghai Dayang Pharmaceutical Co., Ltd. are for Jiuzhoutong. The layout of the commercial layout is more reasonable, further improving the company's terminal coverage capabilities.

Jiuzhoutong has a subsidiary in Anhui, with a revenue of 42.94 million yuan in the first half of 2016 and a net profit of 2.34 million yuan. The official website of Jiuzhou Tongyu said that under the leadership of the Jiuzhoutong Group, the Jiuzhou Kyushu will be the most professional and excellent pharmaceutical distribution enterprise in the northern part of the country. Obviously, the Jiuzhoutong of Puyang is mainly continuing to expand and strengthen the local distribution. strength.

As the leader of private distribution companies, corporate name-recognition information may only show a small part of its pharmaceutical circulation layout, and its 2016 annual report may reveal more content.

Veterinary Products

Bolus, Powders, Injections and other dosage forms for animal use.

Veterinary medicine is informally as old as the human/animal bond but in recent years has expanded exponentially because of the availability of advanced diagnostic and therapeutic techniques for most species.

Veterinary drugs used properly, medications are a safe way to keep animals in good condition while preventing the spread of disease to other animals and neighbouring herds or flocks. They help to prevent costly losses to agricultural producers.

Veterinary products list

Vet Products,Veterinary Drugs,Veterinary Formula,Veterinary Pharmaceuticals

NINGBO VOICE BIOCHEMIC CO. LTD , https://www.medicine-voice.com